4//SEC Filing
Haqq Christopher 4
Accession 0001601485-24-000049
CIK 0001601485other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:12 PM ET
Size
5.7 KB
Accession
0001601485-24-000049
Insider Transaction Report
Form 4
Haqq Christopher
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-09-30+28,200→ 28,200 totalExercise: $5.03Exp: 2024-09-30→ Common Stock (28,200 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001612095
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:12 PM ET
- Size
- 5.7 KB